About Us
Faculty
Research
Education
Divisions
Centers
Patient Care

Home » Faculty » Academic Faculty » Kevin A. Ault, MD

Kevin A. Ault, MD - Associate Professor

kevin_ault

Gynecology, Infectious Disease

 

Academic Office
Emory University School of Medicine
Department of Gynecology and Obstetrics
Division of Gynecologic Oncology
Glenn Building
69 Jesse Hill, Jr., Drive, S.E., Rm 406
Atlanta, GA 30303
Phone · 404-251-8809
Fax · 404-521-3589
E-Mail · kault@emory.edu

Clinical Office
The Emory Clinic
Bldg A, 4th Floor
1365 Clifton Rd.
Atlanta, Ga 30322
Patient Appointments · 404-778-3401



Education
Medical School: Indiana University College of Medicine, Indianapolis, Indiana
Residency: Obstetrics and Gynecology, Ohio State University, Columbus, Ohio
Fellowship: University of Kansas Medical Center, Kansas City, Kansas, Division of Infectious Diseases

Board certifications
Diplomate, American Board of Obstetrics and Gynecology, 1995

 

Awards, Honors, Leadership Positions
1995 American College of Obstetricians and Gynecologists/Curatek Research award in Lower Genital Infections
2005 Presidential Lecture, 13th European Cancer Conference
2007 John Brewer Memorial Lecture, American College of Obstetricians and Gynecologists
2007 Robert Todd Duncan Alumni Achievement Award, Butler University
Fellow, Infectious Disease Society of America
Examiner, American Board of Obstetrics and Gynecology 

Professional societies and memberships
Fellow, 1997 – Present, American College of Obstetricians and Gynecologists
1991 – Present, American Society for Microbiology
1995 – Present, International Infectious Disease Society for Obstetrics and Gynecology
1997 – Present, Infectious Diseases Society for Obstetrics and Gynecology
1999 – Present, International Society for STD Research

Research focus and special interests
Dr. Ault's research clinical interests are infectious diseases and women's health.  He has been an investigator in a wide variety of translational and clinical research involving vaginitis, gonorrhea, Chlamydia, herpes and human papillomavirus.  Recent research projects include HPV vaccine development and immunology, HPV detection in pap smears and the use of molecular techniques to examine the normal vaginal flora.  Dr. Ault also participates as an investigator in the Emory Vaccine Center, and this work includes maternal vaccination for influenza.  Dr. Ault is a fellow of the American College of Obstetricians and Gynecologists and a fellow of the Infectious Society of America, and is one of the few physicians in the United States with both of these honors.  He is also an examiner with the American Board of Obstetrics and Gynecology and the faculty advisor for the Luella Klein Society, a group for Emory medical students with a career interest in women's health.  

 

Selected Publications 2007-2010

What you need to know about STDs, Ault KA, ACOG News, May 18, 2010, ACOG YouTube Channel

Ravela J, Gajera P, Abdob Z, Schneider GM, Koeniga SSK, McCullea SL, Karlebach S, Gorlee R, Russell J, Tacket CO, Brotman RM, Davis CC, Ault K, Peralta L, and Forney LJ.  Vaginal microbiome of reproductive-age women.  Proceedings of the National Academy of Sciences, June 3, 2010.
http://www.labspaces.net/104215/Study_finds_vaginal_microbes_vary_among_healthy_women - press release
http://www.pnas.org/content/early/2010/06/02/1002611107.full.pdf+html - full text

Fraser C,  Tomassini J, Xi L, Golm G, Watson M, Giuliano A,  Barr E, Ault KA. Modeling the Long-term Antibody Response of a Human Papillomavirus (HPV) Virus-like Particle (VLP) Type 16 Prophylactic Vaccine.  Vaccine  2007 25:4324-4333.  

Koutsky L and the FUTURE II Study Group (including Ault KA). Efficacy and safety of a prophylactic  quadrivalent human papillomavirus (types 6/11/16/18) L1 virus-like-particle vaccine in the prevention of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a randomized controlled trial. N Engl J Med 2007 356:1915-1927.

Ault KA and the FUTURE II Study Group.  Prophylactic use of human papillomavirus (HPV) L1 virus-like particle vaccine significantly reduces cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ risk: a combined analysis of four efficacy trials.  The Lancet 2007 369:1861-1868.12.

Joura E and the FUTURE II Study Group (including Ault KA).  HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine. Vaccine 2008 26:6844-6851.

Munoz N. Manalastas R,  Pitisuttithum P,  Tresukosol D, et al.,  (including Ault KA).  Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial. The Lancet.  373:1949-57. 2009.

Tamma P, Ault KA, del Rio C, Steinhoff M, Halsey N, Omer S. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol 201:547-552.  2009. 

Ravel J.  Gajer P, Abdo Z, Schneider M et al (including Ault KA). The vaginal microbiome of reproductive age women.  Proceedings of the National Academy of Sciences.  In press.

Abstract from the AACR Cancer Prevention conference - Participation in HPV vaccination at an urban medical center http://www.medscape.com/viewarticle/732267

American Public Media Marketplace - Travel Song story from Kevin Ault:
You can hear the story, titled "ROAD WARRIORS: Kevin Ault", on the Marketplace website, at http://marketplace.publicradio.org/display/web/2010/11/15/pm-road-warriors-kevin-ault/